Ionis Pharmaceuticals, Inc. <IONS.O>: BMO cuts target price to $54 from $61
IONS•Related News
D-Wave gains access to up to USD 100 million in US CHIPS Act funding under Commerce agreement
QBTS•
Bread Financial CFO to speak at Barclays Global Financial Services Conference fireside chat
BFH•
Cognition Therapeutics CEO Lisa Ricciardi presents at H.C. Wainwright Global Investment Conference
CGTX•
OptimizeRx management participates in Lake Street Capital Best Ideas Growth Conference
OPRX•
Vor Bio highlights telitacicept BAFF/APRIL inhibitor as lead program in B cell-driven autoimmune diseases
VOR•